Second, studies of genetic alterations in chordoma identified mutation or loss of the cell cycle regulator CDKN2A (39, 45), which is of interest since we identified CDKN2C and CDKN3 as hits in a screen for proteins whose depletion enhances sensitivity to IGF-1R inhibition (46). This evidence concerns the gene CDKN2C and chordoma.